Copyright Reports & Markets. All rights reserved.

Asia-Pacific Pharma Ophthalmic Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Pharma Ophthalmic Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Retinal disorders drugs Market Performance (Volume)
      • 2.1.2 Allergic, inflammatory and infective drugs Market Performance (Volume)
      • 2.1.3 Glaucoma drugs Market Performance (Volume)
      • 2.1.4 Dry eye drugs Market Performance (Volume)
      • 2.1.5 Other ophthalmic drugs Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Retinal disorders drugs Market Performance (Value)
      • 2.1.2 Allergic, inflammatory and infective drugs Market Performance (Value)
      • 2.1.3 Glaucoma drugs Market Performance (Value)
      • 2.1.4 Dry eye drugs Market Performance (Value)
      • 2.1.5 Other ophthalmic drugs Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Glaucoma Market Performance (Volume)
      • 3.1.2 Dry eye syndrome Market Performance (Volume)
      • 3.1.3 Retinal diseases Market Performance (Volume)
      • 3.1.4 Other ophthalmic indications Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Novartis
      • 4.1.1 Novartis Profiles
      • 4.1.2 Novartis Product Information
      • 4.1.3 Novartis Pharma Ophthalmic Business Performance
      • 4.1.4 Novartis Pharma Ophthalmic Business Development and Market Status
    • 4.2 Allergan
      • 4.2.1 Allergan Profiles
      • 4.2.2 Allergan Product Information
      • 4.2.3 Allergan Pharma Ophthalmic Business Performance
      • 4.2.4 Allergan Pharma Ophthalmic Business Development and Market Status
    • 4.3 Roche
      • 4.3.1 Roche Profiles
      • 4.3.2 Roche Product Information
      • 4.3.3 Roche Pharma Ophthalmic Business Performance
      • 4.3.4 Roche Pharma Ophthalmic Business Development and Market Status
    • 4.4 Valeant
      • 4.4.1 Valeant Profiles
      • 4.4.2 Valeant Product Information
      • 4.4.3 Valeant Pharma Ophthalmic Business Performance
      • 4.4.4 Valeant Pharma Ophthalmic Business Development and Market Status
    • 4.5 Regeneron
      • 4.5.1 Regeneron Profiles
      • 4.5.2 Regeneron Product Information
      • 4.5.3 Regeneron Pharma Ophthalmic Business Performance
      • 4.5.4 Regeneron Pharma Ophthalmic Business Development and Market Status
    • 4.6 Santen
      • 4.6.1 Santen Profiles
      • 4.6.2 Santen Product Information
      • 4.6.3 Santen Pharma Ophthalmic Business Performance
      • 4.6.4 Santen Pharma Ophthalmic Business Development and Market Status
    • 4.7 Bayer
      • 4.7.1 Bayer Profiles
      • 4.7.2 Bayer Product Information
      • 4.7.3 Bayer Pharma Ophthalmic Business Performance
      • 4.7.4 Bayer Pharma Ophthalmic Business Development and Market Status
    • 4.8 Pfizer
      • 4.8.1 Pfizer Profiles
      • 4.8.2 Pfizer Product Information
      • 4.8.3 Pfizer Pharma Ophthalmic Business Performance
      • 4.8.4 Pfizer Pharma Ophthalmic Business Development and Market Status
    • 4.9 Senju
      • 4.9.1 Senju Profiles
      • 4.9.2 Senju Product Information
      • 4.9.3 Senju Pharma Ophthalmic Business Performance
      • 4.9.4 Senju Pharma Ophthalmic Business Development and Market Status
    • 4.10 Akorn
      • 4.10.1 Akorn Profiles
      • 4.10.2 Akorn Product Information
      • 4.10.3 Akorn Pharma Ophthalmic Business Performance
      • 4.10.4 Akorn Pharma Ophthalmic Business Development and Market Status

    5 Market Performance for Manufacturers

    • 5.1 Asia-Pacific Pharma Ophthalmic Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 Asia-Pacific Pharma Ophthalmic Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 Asia-Pacific Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 Asia-Pacific Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Pharma Ophthalmic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 China Pharma Ophthalmic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 China Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 China Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 Japan Market Performance for Manufacturers
      • 6.2.1 Japan Pharma Ophthalmic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 Japan Pharma Ophthalmic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 Japan Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 Japan Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 South Korea Market Performance for Manufacturers
      • 6.3.1 South Korea Pharma Ophthalmic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 South Korea Pharma Ophthalmic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 South Korea Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 South Korea Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 Taiwan Market Performance for Manufacturers
      • 6.4.1 Taiwan Pharma Ophthalmic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 Taiwan Pharma Ophthalmic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 Taiwan Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 Taiwan Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration
    • 6.5 India Market Performance for Manufacturers
      • 6.5.1 India Pharma Ophthalmic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.5.2 India Pharma Ophthalmic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.5.3 India Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.5.4 India Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
      • 6.5.5 Market Concentration
    • 6.6 Southeast Asia Market Performance for Manufacturers
      • 6.6.1 Southeast Asia Pharma Ophthalmic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.6.2 Southeast Asia Pharma Ophthalmic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.6.3 Southeast Asia Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.6.4 Southeast Asia Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
      • 6.6.5 Market Concentration
    • 6.7 Australia Market Performance for Manufacturers
      • 6.7.1 Australia Pharma Ophthalmic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.7.2 Australia Pharma Ophthalmic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.7.3 Australia Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.7.4 Australia Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
      • 6.7.5 Market Concentration
    • 6.8 Market Performance for Manufacturers
      • 6.8.1 Pharma Ophthalmic Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.8.2 Pharma Ophthalmic Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.8.3 Pharma Ophthalmic Price (USD/Unit) of Manufacturers 2013-2018
      • 6.8.4 Pharma Ophthalmic Gross Margin of Manufacturers 2013-2018
      • 6.8.5 Market Concentration

    7 Asia-Pacific Pharma Ophthalmic Market Performance (Sales Point)

    • 7.1 Asia-Pacific Pharma Ophthalmic Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 Asia-Pacific Pharma Ophthalmic Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 Asia-Pacific Pharma Ophthalmic Price (USD/Unit) by Regions 2013-2018
    • 7.4 Asia-Pacific Pharma Ophthalmic Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 Asia-Pacific Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 China Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 Japan Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 South Korea Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 Taiwan Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.6 India Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.7 Southeast Asia Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Australia Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.8 Australia Pharma Ophthalmic Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Glaucoma Industry
    • 11.2 Dry eye syndrome Industry
    • 11.3 Retinal diseases Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 Asia-Pacific Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 Asia-Pacific Pharma Ophthalmic Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 China Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 Japan Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 South Korea Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 Taiwan Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 India Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Southeast Asia Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Australia Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.10 Pharma Ophthalmic Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Retinal disorders drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Allergic, inflammatory and infective drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.4 Glaucoma drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.5 Dry eye drugs Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Glaucoma Sales and and Growth Rate 2019-2024
      • 12.4.3 Dry eye syndrome Sales and and Growth Rate 2019-2024
      • 12.4.4 Retinal diseases Sales and and Growth Rate 2019-2024
      • 12.4.5 Other ophthalmic indications Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 Asia-Pacific Pharma Ophthalmic Price (USD/Unit) Trend 2019-2024
      • 12.5.2 Asia-Pacific Pharma Ophthalmic Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Pharma Ophthalmic for these regions, from 2012 to 2023 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

    Asia-Pacific Pharma Ophthalmic market competition by top manufacturers/players, with Pharma Ophthalmic sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Novartis
    Allergan
    Roche
    Valeant
    Regeneron
    Santen
    Bayer
    Pfizer
    Senju
    Akorn

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Retinal disorders drugs
    Allergic, inflammatory and infective drugs
    Glaucoma drugs
    Dry eye drugs
    Other ophthalmic drugs

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Pharma Ophthalmic for each application, including
    Glaucoma
    Dry eye syndrome
    Retinal diseases
    Other ophthalmic indications

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now